Macquarie University conducted a Rapid Literature Review in March 2024, highlighting the widespread adoption of pathology Point of Care Testing (PoCT) devices in Australia. The Executive Summary highlights the significant benefits of PoCT, but also notable safety and quality challenges. 

The Requirements for cervical screening (Third edition 2025) sets out the standards for using human papillomavirus nucleic acid testing as the primary screening method for cervical cancer screening. 

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA)...

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA)...

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA)...

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA)...

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA)...

This document provides guidance for providers of Direct to Consumer Genetic Testing with the aim of ensuring the quality of services and the safety of clients. These principles for the provision of direct to consumer genetic tests are based on the United Kingdom (UK) Genetics Commissions Direct-to-Consumer Principles Framework having...

The document describes the role and responsibilities of the Designated Person described in the Tier 2 document Requirements for Medical Pathology Services.

This fact sheet provides an overview of the National Pathology Accreditation Scheme.